Resource Tag: ANTIPSYCHOTIC DRUGS
LCSH
Antipsychotic Drugs in Bipolar Disorder
This article reviews the use of antipsychotic drugs in the treatment of acute mania & as maintenance treatment. The evidence for the use of atypical antipsychotic drugs, including their effects on suicidal behaviours, is discussed. Clozapine, risperidone, olanzapine, & other atypic antipsychotics are reviewed. (59 refs.)
Strategies to Prevent Suicide
These letters to the editor comment on a previous article by Mann et al (2005) on suicide prevention strategies. Tondo & Baldessarini note the lack of discussion of disorders other than major depression & treatments other than antidepressants. Knox & Caine provide more information on the Air Force Suicide Prevention Program, disputing Mann et al’s […]
Impact of Clozapine on Completed Suicide
For commentary on this article and reactions to these findings, please see SIEC #2005-0085
Clozapine and Suicide
For the original article by Sernyak et al., please see SIEC #2005-0078
Clozapine and Postmortem Redistribution
The authors present a case study in which a patient being treated with clozapine was found dead with toxic levels of the drug in her blood. While the coroner expressed concern over the possibility of suicide, the authors argue that the elevated drug concentrations might instead have been caused by a postmortem redistribution of clozapine […]
Decreasing Suicide in Schizophrenia
For Part 1 of this series, please see SIEC #2005-0439
Decreasing Suicide in Schizophrenia
For Part 2 of this series, please see SIEC #2005-0438
Suicide Victims With Schizophrenia in Different Treatment Phases and Adequacy of Antipsychotic Treatment
Published in “The Suicidal Process: Challenges for Treatment and Prevention”
Clozapine may be More Effective than Olanzapine for Reducing Suicidal Behaviour in People with Schizophrenia at High Risk
Please see SIEC #2003-1344 for the citation to the Meltzer et al article.
A Randomized Double-Blind Study of Risperidone and Olanzapine in the Treatment of Schizophrenia or Schizoaffective Disorder
The safety & efficacy of risperidone & olanzapine were compared in a double-blind trial that used doses widely accepted in clinical trials. During the study, serious adverse events were experienced by 8.0% of the risperidone participants & 11.6% of the olanzapine participants. The second most frequently recorded serious adverse event was suicide attempt, which was […]
Reducing the Risk for Suicide in Schizophrenia and Affective Disorders: Suicide in Schizophrenia
For a related article on treatment & suicide risks in affective disorders, please see SIEC #2004-0558
Modelling the Impact of Clozapine on Suicide in Patients With Treatment-Resistant Schizophrenia in the UK
In order to model the impact of increased clozapine prescribing on lives saved & resource utilization, a model was built to compare current levels of clozapine prescribing with a scenario in which all suitable patients with treatment-resistant schizophrenia received clozapine. It was estimated that an average of 53 lives could be saved in the UK […]
Contributions of 5-HT2C Receptors to Multiple Actions of Central Serotonin Systems
The authors discuss the contributions of a prominent central serotonin subtype, the 5-HT2C receptor, to the actions of serotonin. Evidence for a role of these receptors in affect regulation, gathered from observations of the brains of suicide victims with a history of depression, is explored. (90 refs)
Do Antipsychotic Medications Decrease the Risk of Suicide in Patients With Schizophrenia?
This review brings together evidence from controlled studies regarding the benefits provided by antipsychotic medications against suicide & suicide attemtps in schizophrenia. (43 refs)